Affimed to Present at the Jefferies 2015 Healthcare Conference -- New York
May 27, 2015 05:00 ET
|
Affimed NV
HEIDELBERG, Germany, May 27, 2015 (GLOBE NEWSWIRE) -- Affimed (Nasdaq:AFMD) today announced that Dr. Adi Hoess, CEO, will present a corporate overview at the Jefferies 2015 Healthcare Conference...
Affimed Announces First Quarter 2015 Financial Results Conference Call
May 13, 2015 06:03 ET
|
Affimed NV
Heidelberg, Germany, May 13, 2015 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) today announced that on May 21, 2015, the Company will release its financial results for the quarter ended March 31,...
Affimed N.V. Announces Proposed Public Offering of Common Stock
May 04, 2015 16:08 ET
|
Affimed NV
HEIDELBERG, Germany, May 4, 2015 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage biopharmaceutical company developing highly targeted cancer immunotherapies, today announced that it...
Affimed Announces Financial Results for Fourth Quarter and Year End 2014
March 25, 2015 07:41 ET
|
Affimed NV
HEIDELBERG, Germany, March 25, 2015 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage biopharmaceutical company developing highly targeted cancer immunotherapies, today reported...